Hypermarcas (OTCMKTS:HYPMY) Short Interest Update

Hypermarcas (OTCMKTS:HYPMY) was the target of a large growth in short interest in June. As of June 30th, there was short interest totaling 2,046 shares, a growth of 12,687.5% from the June 15th total of 16 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 33,339 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Hypermarcas has a consensus rating of “Buy”.

Hypermarcas Stock Up 3.3%

HYPMY traded up $0.13 during midday trading on Friday, hitting $4.09. 2,969 shares of the company traded hands, compared to its average volume of 20,966. The firm has a market capitalization of $2.88 billion, a PE ratio of 8.52 and a beta of 0.71. The company’s 50-day moving average is $4.28 and its 200 day moving average is $4.39. Hypermarcas has a 52 week low of $3.71 and a 52 week high of $5.50.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The firm had revenue of $383.13 million during the quarter. On average, sell-side analysts predict that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.